Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) EBT Margin (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed EBT Margin for 14 consecutive years, with 0.75% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 5010.0% to 0.75% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 20.36% through Dec 2025, up 1278.0% year-over-year, with the annual reading at 20.36% for FY2025, 1033.0% up from the prior year.
  • EBT Margin hit 0.75% in Q4 2025 for STRATA Skin Sciences, up from 23.41% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 14.71% in Q2 2021 to a low of 49.84% in Q1 2024.
  • Historically, EBT Margin has averaged 22.65% across 5 years, with a median of 23.49% in 2025.
  • Biggest five-year swings in EBT Margin: surged 5523bps in 2021 and later crashed -4381bps in 2023.
  • Year by year, EBT Margin stood at 9.13% in 2021, then soared by 90bps to 0.91% in 2022, then plummeted by -4788bps to 44.72% in 2023, then dropped by -10bps to 49.34% in 2024, then soared by 102bps to 0.75% in 2025.
  • Business Quant data shows EBT Margin for SSKN at 0.75% in Q4 2025, 23.41% in Q3 2025, and 33.6% in Q2 2025.